Mirum Pharmaceuticals's three largest insider shareholders as of March 23, 2026 are Enterprise Associates 16, L.P. New (TenPercentOwner, 2.19Mn shares), Partners 16, L.P. Nea (TenPercentOwner, 2.19Mn shares), Niall O'Donnell (Director, 1.62Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Enterprise Associates 16, L.P. New | 2,186,243 | 0 | 15 Jun, 2023 | |
| Partners 16, L.P. Nea | 0 | 2,186,243 | 15 Jun, 2023 | |
| Niall O'Donnell | 0 | 1,621,118 | 15 Nov, 2022 | |
| Christopher Peetz | Chief Executive Officer | 194,309 | 0 | 17 Mar, 2026 |
| Christopher Peetz | Chief Executive Officer | 0 | 187,500 | 02 Jan, 2026 |
| Eric Bjerkholt | Chief Financial Officer | 49,788 | 0 | 17 Mar, 2026 |
| Edwin Jonathan Tucker | Chief Medical Officer | 45,838 | 0 | 15 Nov, 2021 |
| Peter Radovich | President And Coo | 40,272 | 0 | 17 Mar, 2026 |
| Pamela Vig | Chief Scientific Officer | 27,406 | 0 | 25 Jun, 2024 |
| Joanne Quan | Chief Medical Officer | 18,864 | 0 | 17 Mar, 2026 |
| Anthony A. Jr. Florence | 384 | 11,348 | 15 Jun, 2023 | |
| Scott D Sandell | 0 | 11,348 | 15 Jun, 2023 | |
| Jolanda Howe | Svp, Global Controller | 8,429 | 0 | 17 Mar, 2026 |
| Timothy P Walbert | 5,703 | 0 | 02 Jun, 2025 | |
| Forest Baskett | 0 | 1,548 | 15 Jun, 2023 | |
| Ali Behbahani | 0 | 135 | 15 Jun, 2023 | |
| Carmen Chang | 135 | 0 | 15 Jun, 2023 | |
| Paul Edward Walker | 0 | 114 | 15 Jun, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 16 Mar, 2026 | Saira Ramasastry | Common Stock | A | 2,000 | $23.51 | 2,000 | D | M |
| 15 Mar, 2026 | Peter Radovich | Common Stock | A | 7,220 | - | 33,787 | D | M |
| 15 Mar, 2026 | Joanne Quan | Common Stock | A | 13,334 | - | 26,151 | D | M |
| 15 Mar, 2026 | Jolanda Howe | Common Stock | A | 2,658 | - | 7,161 | D | M |
| 15 Mar, 2026 | Christopher Peetz | Common Stock | A | 25,000 | - | 185,294 | D | M |
| 15 Mar, 2026 | Eric Bjerkholt | Common Stock | A | 13,334 | - | 57,075 | D | M |
| 15 Mar, 2026 | Peter Radovich | Common Stock | A | 23,000 | - | 56,787 | D | M |
| 16 Mar, 2026 | Joanne Quan | Common Stock | D | 7,287 | $91.98 | 18,864 | D | S |
| 15 Mar, 2026 | Jolanda Howe | Common Stock | A | 6,000 | - | 13,161 | D | M |
| 16 Mar, 2026 | Saira Ramasastry | Common Stock | D | 2,000 | $90.76 | 0 | D | S |
| 16 Mar, 2026 | Eric Bjerkholt | Common Stock | D | 7,287 | $91.98 | 49,788 | D | S |
| 15 Mar, 2026 | Christopher Peetz | Common Stock | A | 50,000 | - | 235,294 | D | M |
| 15 Mar, 2026 | Eric Bjerkholt | Performance Restricted Stock Units | D | 13,334 | $0.00 | 6,666 | D | M |
| 16 Mar, 2026 | Jolanda Howe | Common Stock | D | 4,732 | $91.98 | 8,429 | D | S |
| 16 Mar, 2026 | Christopher Peetz | Common Stock | D | 40,985 | $91.98 | 194,309 | D | S |
| 15 Mar, 2026 | Joanne Quan | Performance Restricted Stock Units | D | 13,334 | $0.00 | 6,666 | D | M |
| 16 Mar, 2026 | Peter Radovich | Common Stock | D | 16,515 | $91.98 | 40,272 | D | S |
| 16 Mar, 2026 | Saira Ramasastry | Stock Option (right to buy) | D | 2,000 | $0.00 | 4,000 | D | M |
| 15 Mar, 2026 | Peter Radovich | Performance Restricted Stock Units | D | 7,220 | $0.00 | 0 | D | M |
| 15 Mar, 2026 | Jolanda Howe | Performance Restricted Stock Units | D | 2,658 | $0.00 | 0 | D | M |